Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - Shrink Nanotechnologies, Inc. | ex991.htm |
8-K - INKN FORM 8-K (5-3-10) - Shrink Nanotechnologies, Inc. | inknform8k050310.htm |
EX-10.1 - EXHIBIT 10.1 - Shrink Nanotechnologies, Inc. | ex101.htm |
EX-99.2 - EXHIBIT 99.2 - Shrink Nanotechnologies, Inc. | ex992.htm |
EX-10.2 - EXHIBIT 10.2 - Shrink Nanotechnologies, Inc. | ex102.htm |
EX-99.3 - EXHIBIT 99.3 - Shrink Nanotechnologies, Inc. | ex993.htm |
SHRINK
NANOTECHNOLOGIES EXECUTES 3-YEAR SPONSORED RESEARCH AGREEMENT WITH LEADING
SCIENCE AND ENGINEERING
PUBLIC
UNIVERSITY IN CALIFORNIA
--Agreement
to Grant Exclusive Access to Intellectual Property From Acclaimed Research Lab
--
CARLSBAD, CA – MAY 6, 2010 –
Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN); (OTCBB: INKND), an
innovative nanotechnology company developing products and licensing
opportunities in the solar energy production, medical diagnostics and sensors
and biotechnology research and development tools businesses, announced today
that it has entered into a three-year sponsored research agreement with a
leading science and engineering campus within the largest public university
system in the state of California. The multi-year sponsored research
project (“the Project”) focuses on developing commercial applications for
shrinkable plastic-based biological chips and devices for commercial high-volume
applications such as ultra-functional immunoassay substrates and biotechnology
and stem cell research tools. According to the agreement, inventions developed
from July of 2009 through the end of the three year term will exclusively be
available to Shrink.
“Consistent
with our FIGA business model (interconnecting leaders from finance, industry,
government and academia), Shrink is committed to leveraging the value of
underutilized public university assets, including facilities and most
importantly, the brilliant minds that conduct ground-breaking research on a
day-to-day basis. I am astounded when I contemplate the contribution
public and private universities have made to the American business
landscape. Many of the largest companies in the world came of
university laboratories, especially those in the United States. At
Shrink, as a small company living in a technologically advanced and
interconnected world, we believe in utilizing these assets, especially in light
of the drastic reductions many universities have seen in funding commitments
from donor commercial businesses. This reality is an opportunity for
Shrink to chart a path, build important long-term relationships, do great
research and help build our company into an organization that will one day lead
in a number of large and growing markets,” said Mark L. Baum, CEO of Shrink
Nanotechnologies, Inc.
Baum
added, “Regarding this specific agreement, in terms of access to intellectual
property, we were able to negotiate a deal which, with respect to intellectual
property, actually predated the date we executed the agreement. In
other words, we were able to access, exclusively, inventions from as far back as
the middle of last year. We believe that this will be important to
our company and our shareholders as we continue to accumulate unique and
hopefully financially accretive intellectual property assets. As
important, our company will have the right to turn these technologies into
products that make a difference in people’s lives.”
Shrink’s
academic research efforts in the life science arena are focused on developing
and designing integrated, manufacturable nanostructured proprietary substrates
for environmental and biological sensing. The goal of these projects
is to “build a better diagnostic test” – one that is more accurate, sensitive
and specific to a particular condition – like whether one has had a heart
attack, or if they have signs of a particular cancer or if there is arsenic in a
water stream. Shrink is also equally as engaged in the solar and
alternative energy space where it is working with other university relationships
specifically on its unique solar concentrator designs in an effort to build
solar concentrator systems to finally make clean and renewable solar energy make
economic sense without the need for handouts from the government.
About
Shrink Nanotechnologies, Inc.
Shrink
Nanotechnologies, Inc. is a high-technology developing-stage company that makes
ultra-functional nano-sized technologies, components and product systems. The
Company operates as a first of its kind FIGA™ organization. FIGA companies bring
together diverse contributions from leaders in the worlds of finance, industry,
government and academia. The Company's diverse advanced plastic substrates,
nano-devices and biotech research tools, among others, are designed to be
ultra-functional and mechanically superior in the solar energy, environmental
detection, stem cell research tools and biotechnology device markets. The
Company’s products are based on a pre-stressed plastic called NanoShrink™, and
on a patent-pending manufacturing process called the ShrinkChip Manufacturing
Solution™. Shrink’s unique materials and manufacturing solution represents a new
paradigm in the rapid design, low-cost fabrication and manufacture of nano-scale
devices for numerous significant markets.
To learn
more about Shrink Nanotechnologies, Inc. or to download the most up-to-date
shareholder kit, please visit at www.shrinknano.com
and www.shrinksolar.com.
Statements
contained herein that are not historical facts may be forward-looking statements
within the meaning of the Securities Act of 1933, as amended. Forward-looking
statements include statements regarding the intent, belief or current
expectations of the Company and its management. Such statements are estimates
only. Actual results may differ materially from those anticipated in this press
release. Such statements reflect management's current views, are based on
certain assumptions and involve risks and uncertainties. Actual results, events,
or performance may differ materially from the above forward-looking statements
due to a number of important factors, and will be dependent upon a variety of
factors, including, but not limited to Shrink's ability to obtain additional
financing, secure defendable patent rights, to build and develop markets for
Shrink's technologies and products and to finalize a commercial-ready solar
concentrator product and biosensing product. These factors should be strongly
considered when making a decision to acquire or maintain a financial interest in
Shrink, including consulting with a FINRA registered representative prior to
making such decision. Shrink undertakes no obligation to publicly update these
forward-looking statements to reflect events or circumstances that occur after
the date hereof or to reflect any change in Shrink's expectations with regard to
these forward-looking statements or the occurrence of unanticipated events.
Factors that may impact Shrink's success are more fully disclosed in Shrink's
most recent public filings with the U.S. Securities and Exchange
Commission.
See
also:
http://www.shrinksolar.com/blog/
http://www.shrinknano.com/products/product-tools
http://www.shrinknano.com/products/product-diagnostics
http://www.shrinknano.com/tech
http://www.shrinknano.com/tr35-a-children%E2%80%99s-toy-inspires-a-cheap-easy-production-method-for-high-tech-diagnostic-chips
Contact:
For
Shrink Nanotechnologies
Mark L.
Baum, Esq.
760-804-8844
x205